Black Rock Inc. Hoth Therapeutics, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.38 - $1.05 $23,981 - $66,263	-63,108 Reduced 100.0%	1 $0
Q1 2022 May 12, 2022	SELL	$0.52 - $1.3 $1,609 - $4,024	-3,096 Reduced 4.68%	63,109 $43,000
Q4 2021 Feb 10, 2022	BUY	$0.66 - $1.18 $1,135 - $2,029	1,720 Added 2.67%	66,205 $44,000
Q3 2021 Nov 09, 2021	SELL	$1.15 - $1.62 $1,582 - $2,229	-1,376 Reduced 2.09%	64,485 $77,000
Q2 2021 Aug 11, 2021	BUY	$1.31 - $2.14 $86,277 - $140,942	65,861 New	65,861 $105,000

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.11M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.